Influenza Pandemic Preparedness Plan

Objectives

Egypt’s updated Pandemic Influenza Preparedness and Response Plan aims to reduce pandemic influenza morbidity, mortality, transmission and wider social and economic disruption through coordinated, evidence-based and ethically grounded action. It provides a national framework for individuals, facilities and institutions to prepare for and respond to a pandemic while maintaining essential services.[1][2]

• Strengthen preparedness across command and control, surveillance, laboratories, vaccination, infection prevention and control, clinical care, antivirals, non-pharmaceutical interventions, risk communication, training, evaluation and research.[3][4]
• Apply an all-hazards, risk-based continuum covering interpandemic, alert, pandemic and transition phases, with national and local risk assessments guiding action rather than automatic reliance on World Health Organization global phases.[5][6]
• Prevent or limit importation and early transmission through border measures, case management, contact tracing, contact monitoring or segregation, and containment of sporadic cases or small clusters.[6]
• Shift to mitigation when widespread transmission makes containment impractical, using measures intended to slow transmission, reduce hospital pressure and protect essential services.[6][7]
• Ensure fair, transparent and proportionate decision-making on scarce-resource allocation, vaccination and antiviral prioritisation, movement restrictions, and the responsibilities and protection of health-care workers.[8][9]
• Prioritise vaccine availability, rapid administration to people at risk, vaccine safety and effectiveness monitoring, and increased seasonal influenza vaccination among high-risk groups.[10][11]
• Maintain hospital and primary health-care capacity, including surge arrangements, referrals, workforce protection, medicines, equipment, essential services and management of increased mortality.[12][13][14]
• Support whole-of-society preparedness, business continuity, civil-society participation, community education, social mobilisation and protection of vulnerable populations.[15][16]
• Address evidence gaps through research on disease burden, vaccine and antiviral effectiveness, adverse effects and cost-effectiveness, and influenza molecular and genetic epidemiology.[17]

Implementation

Implementation is led by the Ministry of Health and Population through multi-level committees, health-sector operational plans and whole-of-government coordination. The plan combines continuous surveillance and risk assessment with phase-specific public-health action, supported by health directorates, hospitals, primary care, laboratories, quarantine services, other ministries, private providers, communities and international partners.[18][19][15]

• Coordinate national preparedness through the National Superior Committee, which consolidates information, supervises strategy implementation, approves response activation, supports resource availability and exceptional funding, coordinates international assistance, and manages public information and social mobilisation.[19]
• Operate a Ministry of Health and Population Crisis Management Committee and a National Pandemic Inter-Ministerial Committee to coordinate ministry sectors and cross-government incident management during a pandemic.[18][19]
• Use a Risk Assessment Committee to assess the situation continuously, communicate findings to national committees and the World Health Organization, and recommend proportionate response measures.[7]
• Maintain International Health Regulations (2005) arrangements through Ministry reporting as the national focal point, notification of qualifying events to the World Health Organization, and sharing influenza viruses with pandemic potential through the Global Influenza Surveillance and Response System.[9][20]
• Run integrated surveillance through hospital, outpatient, sentinel, laboratory, school, workplace, closed-community and entry-point systems, supported by electronic reporting in governorates, districts and fever and chest hospitals.[21]
• Analyse epidemiological and virological information to detect unusual respiratory trends, assess severity and health-system demand, characterise viruses, monitor antiviral susceptibility and vaccine effects, and adjust response measures.[22][23]
• Strengthen laboratory readiness through the Central Public Health Laboratory as the National Influenza Center, subnational laboratory support, staff training, quality monitoring, secure specimen transport and stockpiled testing supplies.[24]
• Implement vaccination through manufacturer engagement, regulatory review by the National Organization for Research and Control of Biologicals, cold-chain capacity, trained teams, locally distributed supplies, communications and monitoring of coverage, stocks, adverse effects, quality and effectiveness.[11][25][26][27]
• Apply infection prevention and control through triage and patient separation, cohorting or isolation, hand hygiene, personal protective equipment, environmental cleaning, visitor policies, occupational-health measures and surveillance of health-care-associated and health-worker infections.[28][29][30]
• Prepare international entry points through quarantine units, trained personnel, traveller screening, thermal scanners, health declarations, dedicated ambulance transfer, traveller information and contact tracing.[31][32]
• Require hospitals and primary health-care facilities to maintain response plans, conduct exercises, train personnel, establish referral pathways, protect staff, manage surge capacity, preserve essential services and maintain stocks of medicines, protective equipment and clinical supplies.[33][12][34][35]
• Engage private facilities, businesses and civil society in patient care, workforce protection, continuity planning, volunteer mobilisation, support for vulnerable groups and public education.[16][35][36]
• Use communication, hygiene advice, voluntary isolation, household measures, school or workplace interventions and modifications to mass gatherings according to assessed severity and local circumstances.[36][37][38][39]
• Mobilise resources through national stockpiles, facility-level supply planning and Ministry of Finance support under a pre-set emergency budget; however, the supplied material does not provide total programme costs or detailed budget allocations.[19][40][41]

Monitoring & Evaluation

Egypt’s pandemic influenza plan establishes a layered monitoring and accountability system centred on continuous risk assessment, integrated surveillance, laboratory confirmation, routine reporting and committee-led decision-making. Risk assessment is intended to guide movement across inter-pandemic, alert, pandemic and transition phases, with national and local assessments informing proportionate action alongside World Health Organization (WHO) global phases.[5][6]The Risk Assessment Committee communicates findings to the Crisis Management Committee and National Pandemic Inter-Ministerial Committee, while updated national information is shared with WHO.[7]

• Maintain nationwide indicator-based, event-based, hospital, outpatient, sentinel, laboratory, school, workplace, closed-community and entry-point surveillance to detect novel influenza, describe transmission and severity, and identify public-health needs.[21][22][23]
• Collect and analyse data on geographic spread, epidemic trends, hospitalisations, complications, deaths, risk groups, intensive-care demand, absenteeism, viral characteristics, antiviral susceptibility and vaccine effectiveness.[22][23][10]
• Operate electronic reporting through the National Egyptian Disease Surveillance System across 27 governorates, 270 health districts and fever and chest hospitals, with governorate surveillance units submitting collated data to the Department of Disease Epidemiology and Surveillance.[21]
• Produce weekly reports on pneumonia, avian influenza, severe acute respiratory infection and influenza-like illness at sentinel sites, and submit daily case, death, hospital-capacity and absenteeism information through directorates, districts, hospitals, emergency rooms and central ministry systems.[21][23][17][42]

Defined reporting triggers include notification when more than 10% of students or workers in a governorate are absent because of influenza-like illness in one week, followed by collection of at least two suspected-case samples for Central Public Health Laboratory testing.[21][22]National respiratory triggers also include unexpected disease trends, severe respiratory clusters, unusual mortality or clinical patterns, unexplained illness among relevant health-care workers, increased pharmaceutical sales and novel influenza infections.[7]

Laboratory surveillance is coordinated by the Central Public Health Laboratory, Egypt’s National Influenza Center, supported by eight subnational laboratories and connected to the WHO Global Influenza Surveillance and Response System.[24]Laboratory monitoring covers safe specimen collection and transport, testing quality, antigenic and genetic changes, antiviral sensitivity, and release of results.[24][10]Confirmed influenza is based on positive polymerase chain reaction testing or virus isolation from nasopharyngeal swabs.[21]

Monitoring extends to programme delivery. Vaccination monitoring includes immediate adverse-event reporting, weekly governorate lists of vaccinated people, stock review, coverage measurement by target group, unused-dose counts, cold-chain assessment and post-marketing surveillance by the National Organization for Research and Control of Biologicals.[26][27][43]Hospital and primary health-care plans require daily case reporting, infection-prevention monitoring, facility-resource data collection, regular stock tracking and twice-yearly simulation exercises followed by documented corrective action.[12][41][13]

Accountability is principally administrative and committee-based. The National Superior Committee supervises preparedness implementation, coordinates sectors and approves response activation, while the Ministry of Health and Population Crisis Management Committee maintains continuous epidemiological follow-up and operational readiness.[19][15]International reporting follows the International Health Regulations (2005): Health Directorates report relevant events to the Ministry, which acts as the national focal point and communicates with WHO when notification criteria are met.[20]The plan does not provide a consolidated national indicator framework, independent audit process, comprehensive evaluation timetable or standardised performance targets beyond the specified surveillance, reporting, exercise and review arrangements.[6][44][45]

Costing & Financing

The plan identifies substantial operational resource requirements and assigns financing responsibilities, but provides very limited monetary costing. The National Superior Committee is responsible for ensuring resource availability and redistribution according to priorities, providing required funding and arranging exceptional funding where necessary.[19]The Ministry of Finance is assigned to provide resources for implementing the preparedness plan through a pre-set budget released during health threats and emergencies.[40]

• Fund preparedness for surveillance, laboratories, infection prevention and control, quarantine, communications, training, emergency operations, health-facility assessment and continuity of essential services.[15][44][46]
• Maintain strategic supplies of antivirals, vaccines, personal protective equipment, medicines, laboratory reagents, ventilators, intensive-care equipment, ambulances, field-hospital capacity, disinfectants and body-management materials.[44][47][12][13]
• Plan hospital and primary health-care consumable stockpiles for approximately three months, including antivirals, medicines, personal protective equipment, laboratory supplies, X-ray materials and cleaning supplies.[41][35]
• Mobilise funding for pandemic vaccine procurement through the Immunization Advisory Committee, Cabinet and Ministry of Finance, while providing storage, cold-chain equipment, administration supplies, trained staff and communications materials.[11][25][27]

Explicit quantified resource assumptions focus mainly on pharmaceutical and vaccine volumes rather than expenditure. Egypt held a strategic stockpile of 1.2 million oseltamivir packs, raw materials for a further 1.4 million packs, and 250,000 amantadine packs; approximately 25% of the antiviral stockpile was to be retained as strategic backup.[48][49]Pandemic vaccine planning estimated a requirement of about 15 million doses where supply met national needs, with an alternative limited-supply allocation of about 2 million doses.[26]During the 2009 pandemic, Egypt was assigned 5 million vaccine doses, received 1,908,000, used 1,377,810 and retained 530,190 unused doses.[8]

Resource constraints are recognised without quantified financial gaps. The plan identifies shortages in antiviral and personal protective-equipment stockpiles, the need for domestic manufacture of antivirals and personal protective equipment, and the need to plan for workforce absenteeism that may exceed 30% during a pandemic.[8][41]It also identifies unavailable funds for public mask provision and insufficient human and financial resources to install hand-sanitising stations in all public places.[50]Social-distancing measures may generate economic disruption, including workplace interruption, parental leave, and direct costs to organisers and participants when mass events are cancelled.[39][51]

Research financing is described only in general terms: the Ministry of Health and Population provides some funding, alongside potential national and international external sources, for work including vaccine and antiviral cost-effectiveness.[17]Apart from quantified stocks and dose requirements, the plan does not specify total budgets, expenditure allocations, unit costs, funding shares, procurement prices, costing methods, financing gaps or wider economic assumptions.[52][40][17]